Elekta receives EU CE marking for Connexion modular couchtop

 

Elekta's Connexion™ modular couchtop is CE marked and successfully released for sale in the European Union. Connexion meets the clinic's need to tailor patient set-up to accommodate the unique therapy requirements of the individual patient.

With a growing range of imaging and treatment techniques available, couchtops need to be able to support different approaches without compromising patient set-up. With its distinctive modular design, Connexion removes the restrictions of a single couchtop, allowing clinicians to adapt the couch to each patient's needs. The CE marking of Connexion enables clinics and hospitals in Europe to offer exceptional versatility in patient set-up when Elekta begins delivery of the couchtop.

Connexion allows clinics to maintain patient throughput with easily interchangeable, lightweight modules, providing seamless transition of the individual sections, which connect directly to a baseboard and a variety of extensions.

As a single solution, Connexion offers the following fully indexed modules:

  • Imaging Module: Designed to address the needs of IGRT, IMRT and VMAT techniques, this module features low, homogenous beam attenuation properties.
  • Lateral Opening Module: Designed for techniques that use oblique fields, such as SBRT, this module features additional clearance around the couchtop, providing extra flexibility in treatment set-up when needed.
  • Central Opening Module: Enables the reduction of skin doses via a dedicated area where attenuation and dose build-up are minimized.
  • Head and Neck Module: In accordance with Elekta's open system philosophy, this module supports head and neck immobilization, by providing a common interface to a wide range of immobilization solutions.

"The CE marking of Connexion is exciting for the entire Elekta team," says Chris Snook, Director, Elekta Product Supply Centre, Schwabmunchen, Germany. "Connexion represents the next generation of adaptable positioning solutions from Elekta, and is designed to help our customers improve treatment outcomes."

Source:

Elekta

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Elekta. (2023, September 12). Elekta receives EU CE marking for Connexion modular couchtop. News-Medical. Retrieved on November 22, 2024 from https://www.news-medical.net/news/20120329/Elekta-receives-EU-CE-marking-for-Connexion-modular-couchtop.aspx.

  • MLA

    Elekta. "Elekta receives EU CE marking for Connexion modular couchtop". News-Medical. 22 November 2024. <https://www.news-medical.net/news/20120329/Elekta-receives-EU-CE-marking-for-Connexion-modular-couchtop.aspx>.

  • Chicago

    Elekta. "Elekta receives EU CE marking for Connexion modular couchtop". News-Medical. https://www.news-medical.net/news/20120329/Elekta-receives-EU-CE-marking-for-Connexion-modular-couchtop.aspx. (accessed November 22, 2024).

  • Harvard

    Elekta. 2023. Elekta receives EU CE marking for Connexion modular couchtop. News-Medical, viewed 22 November 2024, https://www.news-medical.net/news/20120329/Elekta-receives-EU-CE-marking-for-Connexion-modular-couchtop.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Elekta and the International Atomic Energy Agency (IAEA) partner to improve access to cancer care in underserved countries